News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,268 Results
Type
Article (43599)
Company Profile (352)
Press Release (671317)
Section
Business (212047)
Career Advice (2172)
Deals (37046)
Drug Delivery (108)
Drug Development (84006)
Employer Resources (173)
FDA (16627)
Job Trends (15534)
News (359347)
Policy (34350)
Tag
Academia (2608)
Alliances (51827)
Alzheimer's disease (1291)
Approvals (16577)
Artificial intelligence (163)
Bankruptcy (368)
Best Places to Work (11788)
Biotechnology (223)
Breast cancer (194)
Cancer (1425)
Cardiovascular disease (120)
Career advice (1808)
Cell therapy (294)
Clinical research (67160)
Collaboration (510)
Compensation (271)
COVID-19 (2637)
C-suite (112)
Data (1414)
Diabetes (187)
Diagnostics (6287)
Earnings (87016)
Employer resources (152)
Events (114082)
Executive appointments (407)
FDA (17330)
Funding (446)
Gene therapy (210)
GLP-1 (673)
Government (4522)
Healthcare (19028)
Infectious disease (2737)
Inflammatory bowel disease (117)
Interviews (338)
IPO (16783)
Job creations (4158)
Job search strategy (1551)
Layoffs (455)
Legal (8474)
Lung cancer (208)
Manufacturing (224)
Medical device (13351)
Medtech (13356)
Mergers & acquisitions (20426)
Metabolic disorders (515)
Neuroscience (1634)
NextGen Class of 2024 (6715)
Non-profit (4543)
Northern California (1716)
Obesity (296)
Opinion (226)
Patents (128)
People (58947)
Pharmaceutical (107)
Phase I (20904)
Phase II (29510)
Phase III (22108)
Pipeline (521)
Postmarket research (2682)
Preclinical (8829)
Radiopharmaceuticals (245)
Rare diseases (281)
Real estate (6350)
Regulatory (22869)
Research institute (2383)
Resumes & cover letters (370)
Southern California (1481)
Startups (3780)
United States (15557)
Vaccines (596)
Weight loss (227)
Date
Today (2)
Last 7 days (303)
Last 30 days (2236)
Last 365 days (36189)
2024 (36101)
2023 (40930)
2022 (52113)
2021 (56674)
2020 (55111)
2019 (47824)
2018 (36140)
2017 (33570)
2016 (33169)
2015 (39008)
2014 (32960)
2013 (28077)
2012 (30165)
2011 (30871)
2010 (28889)
Location
Africa (804)
Arizona (205)
Asia (41127)
Australia (6526)
California (3881)
Canada (1472)
China (319)
Colorado (176)
Connecticut (182)
Europe (87981)
Florida (546)
Georgia (136)
Illinois (401)
Indiana (237)
Maryland (649)
Massachusetts (3040)
Michigan (177)
Minnesota (295)
New Jersey (1132)
New York (1101)
North Carolina (788)
Northern California (1716)
Ohio (149)
Pennsylvania (936)
South America (1180)
Southern California (1481)
Texas (569)
Utah (111)
Washington State (410)
715,268 Results for "atyr pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
aTyr Pharma, Inc. announced that the Company will be changing its ticker symbol from “LIFE” to “ATYR.” Effective at the market open on June 5, 2024, the Company’s common stock will trade on the Nasdaq Capital Market under the new symbol “ATYR.”
June 3, 2024
·
4 min read
Press Releases
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors
December 12, 2024
·
4 min read
Press Releases
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
December 9, 2024
·
6 min read
Press Releases
aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis
November 15, 2024
·
4 min read
Press Releases
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024
·
1 min read
Press Releases
aTyr Pharma to Present at Upcoming Investor Conferences
October 31, 2024
·
2 min read
Biotech Beach
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 24, 2024
aTyr Pharma, Inc. announced that the Compensation Committee of aTyr’s Board of Directors has granted two employees nonstatutory stock options to purchase an aggregate of 9,400 shares of aTyr’s common stock, each with an exercise price of $1.86 per share, which is equal to the closing price of aTyr’s common stock on the Nasdaq Capital Market on May 22, 2024, the effective date of the grants.
May 24, 2024
·
1 min read
Biotech Beach
aTyr Pharma to Participate in April Investor Conferences
aTyr Pharma, Inc. today announced that the company will participate in two upcoming investor conferences scheduled to take place in April 2024.
April 1, 2024
·
1 min read
Biotech Beach
aTyr Pharma to Present at Upcoming May 2024 Investor Conferences
aTyr Pharma, Inc. announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present at several upcoming investor conferences scheduled to take place in May and June 2024.
May 6, 2024
·
1 min read
Press Releases
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
December 10, 2024
·
5 min read
1 of 71,527
Next
